Part,  Chapter, Paragraph

 1   II,     5.  5.  3|           gp_en.pdf; last accessed Dec 13, 2007.~European Commission (
 2   II,     5.  5.  3| consultation_en.htm; last accessed Dec 13, 2007.~European Commission (
 3   II,     5.  5.  3|           at: www f; last accessed Dec 13, 2007.~World Health Organization (
 4   II,     5.  5.  3|            at: htt ; last accessed Dec 13, 2007.~World Health Organisation (
 5   II,     5.  5.  3|            at: htt ; last accessed Dec 13, 2007.~World Health Organization (
 6   II,     5.  5.  3|           at: htt 1; last accessed Dec 13, 2007.~World Health Organization (
 7   II,     5.  5.  3|            at: htt ; last accessed Dec 13, 2007.~World Health Organization (
 8   II,     5.  5.  3|    Solutions http f; last accessed Dec 14, 2007.~Wrigley S, Jackson
 9   II,     5.  7.  7|           disease. Kidney Int 2005 Dec;68(6):2801-8.~Hallan SI,
10   II,     5.  7.  7|       study. Kidney Int Suppl 2005 Dec;(99):S16-S19.~Pontoriero
11   II,     5.  9.  7|      perspective. J Laryngol Otol. Dec;117(12):946-50.~ ~L I (2008):
12   II,     9.  5.  6|    Epidemiol Biomarkers Prev. 2006 Dec;15(12):2494-501~ ~Middle
13  III,    10.  2.  1|            Public Health Nutr 2002 Dec, 5 (6B): 1227-1242.~ ~Linseisen
14  III,    10.  2.  1|            Public Health Nutr 2002 Dec, 5 (6B):1243-1258.~ ~Linseisen
15  III,    10.  2.  1|            Public Health Nutr 2002 Dec, 5 (6B): 1287-1296.~ ~Welch
16   IV,    12. 10    |           improved public health” (Dec 2006 and Dec 2007)~ ~Further
17   IV,    12. 10    |       public health” (Dec 2006 and Dec 2007)~ ~Further provisions